PRRT2 and Familial prostate cancer: As demonstrated here in the PC3 prostate cancer and MCF-7 breast cancer cell lines, the percentage of viable cells was significantly lower when 5-FU treatment was carried out in the presence of Cl-amidine and the PKC inhibitor bisindolylmaleimide-I, compared to treatment with 5-FU alone, after only 24 h.